Has $1.15 Million Holdings in Henry Schein, Inc. (HSIC)

After $1.75 actual earnings per share reported by Henry Schein, Inc. for the previous quarter, Wall Street now forecasts 2.29 % EPS growth. Robert W. Baird upgraded shares of Henry Schein from a neutral rating to an outperform rating and upped their target price for the company from $164.00 to $170.00 in a report on Tuesday, January 3rd. The company has a market cap of $6.55 billion, a PE ratio of 12.11 and a beta of 1.10. About 1.19 million shares traded. It is down 4.05% since September 18, 2016 and is uptrending. It has outperformed by 2.21% the S&P500.

Henry Schein, Inc. most recently reported earnings per share (EPS) of $0.88 for the June 2017 versus $0.8 in the same quarter past year, representing 10% growth.

In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the firm's stock in a transaction on Wednesday, September 6th.

According to Zacks, "Henry Schein exited fourth quarter 2016 on a solid note with both earnings and sales beating the Zacks Consensus Estimate". Citigroup maintained the stock with "Buy" rating in Tuesday, September 13 report. Given that its average daily volume over the 30 days has been 488.74 million shares a day, this signifies a pretty significant change over the norm. Henry Schein has a one year low of $73.11 and a one year high of $93.50. It has underperformed by 12.65% the S&P500.

Investors sentiment decreased to 0.81 in Q4 2016. Its up 0.25, from 0.91 in 2016Q3.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HSIC. 70 funds opened positions while 127 raised stakes. Sterling Cap Management Ltd reported 493,893 shares. Champlain Inv Prtnrs has 0.65% invested in Henry Schein, Inc. (NASDAQ:HSIC). Victory Management has 7,856 shares for 0% of their portfolio. Oxford Asset Mngmt reported 161,845 shares. Given that liquidity is king in short-term, HSIC is a stock with 78.83 million shares outstanding that normally trades 2.42% of its float. Institutional investors own 89.11% of the company's stock.

ILLEGAL ACTIVITY WARNING: "Henry Schein, Inc". (NASDAQ:HSIC) for 128 shares. State Board Of Administration Of Florida Retirement System holds 0% or 12,963 shares. Blackrock holds 6,225 shares or 0% of its portfolio. Morgan Stanley reported 0.03% stake. Retirement Sys Of Alabama stated it has 0.03% in Henry Schein, Inc. (NASDAQ:HSIC). Lord Abbett Com Ltd Limited Liability Company accumulated 46,187 shares. $1.60 million worth of Henry Schein, Inc. The share price was last seen -4.75% lower, reaching at $9.03 on Sep. 26,488 shares were sold by PATEL SUNIT S, worth $1.52M on Tuesday, April 4. (NASDAQ:SFLY) shares were sold by LAYNEY TRACY. $950,478 worth of stock was sold by MLOTEK MARK E on Friday, March 17. Jefferies maintained Henry Schein, Inc. Therefore 6% are positive. Level 3 had 32 analyst reports since July 30, 2015 according to SRatingsIntel. UBS maintained the stock with "Buy" rating in Friday, September 15 report. Piper Jaffray Companies initiated coverage on shares of Henry Schein in a report on Monday, June 12th. Evercore downgraded the stock to "Hold" rating in Friday, July 31 report. Also, CFO Steven Paladino sold 13,072 shares of the company's stock in a transaction dated Wednesday, February 22nd. The stock of Henry Schein, Inc. (NASDAQ:SFLY) has "Hold" rating given on Wednesday, June 21 by Jefferies. The firm has "Buy" rating by Jefferies given on Monday, July 10. Jefferies maintained Henry Schein, Inc. (NASDAQ:HSIC), 8 have Buy rating, 0 Sell and 9 Hold. During the same period in the prior year, the firm earned $1.67 EPS.

Zacks Investment Research upgraded shares of Henry Schein, Inc.

More notable recent Henry Schein, Inc. (NASDAQ:HSIC). Cornerstone Advsrs stated it has 0.02% in Henry Schein, Inc.

The stock increased 0.02% or $0.02 on September 15, reaching $87.95. More interesting news about Henry Schein, Inc. (NASDAQ:HSIC). Proshare Lc holds 0.05% of its portfolio in Henry Schein, Inc.

Investors sentiment increased to 1.16 in Q4 2016. Its down 0.19, from 0.94 in 2016Q3. (NYSE:LVLT). Next Gp reported 300 shares or 0% of all its holdings. 46 funds opened positions while 83 raised stakes. Goldman Sachs Grp Inc invested 0% of its portfolio in Seacor Holdings, Inc. Sumitomo Mitsui Asset Mgmt Co holds 22,915 shares. Financial Bank Of Ny Mellon holds 763,502 shares or 0.03% of its portfolio. State Street Corp now owns 3,675,674 shares of the company's stock worth $624,760,000 after purchasing an additional 48,469 shares during the last quarter. Manufacturers Life Insurance The, Ontario - Canada-based fund reported 44,666 shares. Cantab Capital Prns Llp has 0% invested in Shutterfly, Inc. Menta Ltd Co has 0.26% invested in Shutterfly, Inc. Ulysses Ltd invested in 5.56% or 676,788 shares. Edgepoint Invest accumulated 17.50 million shares. Ubs Asset Mgmt Americas Inc invested in 747,316 shares or 0.13% of the stock. Suntrust Banks Inc reported 6,390 shares. (NYSE:LVLT). Dnb Asset Management As holds 0% of its portfolio in Level 3 Communications, Inc. The Connecticut-based Cubist Systematic Strategies Ltd Com has invested 0.06% in PAREXEL International Corporation (NASDAQ:PRXL).

More news for Seacor Holdings, Inc. (NASDAQ:HSIC). Fiduciary Tru owns 2,027 shares or 0.01% of their U.S. portfolio.

Since May 12, 2017, it had 0 insider purchases, and 6 selling transactions for $2.70 million activity.

Like this



19 September 2017
Emmys: 'Handmaid's Tale' Emerges as Big Winner in Night of New Faces
The Handmaid's Tale , based on the 1985 novel by Canadian author Margaret Atwood , had three statuettes going into the halfway point.

19 September 2017
Jurgen Klopp: I don't feel pressure to win trophies at Liverpool
The German will give run outs to goalkeeper Danny Ward, midfielder Marko Grujic and striker Dominic Solanke at the King Power stadium .

19 September 2017
Chickasha Police Investigate Officer-Involved Shooting
Alex Warren Klingler, 61, was identified as the suspect, a Oklahoma State Bureau of Investigation spokeswoman confirmed. Bob Mills Sky News 9 captured footage of the man wearing a bloody shirt with a towel wrapped around his neck.

19 September 2017
Minnesota teen's death at NDSU dorm under investigation
Delaney had reportedly been spending the weekend with a friend on the seventh floor of Sevrinson Hall at NDSU. NDSU Police say they found an unresponsive 17-year-old boy at Sevrinson Hall just after noon Sunday.

19 September 2017
RBI Considering to Introduce its Own Cryptocurrency Similar to Bitcoin
CBOE Holdings Inc has applied with USA regulators to handle a bitcoin futures contract and an exchange-traded fund. CEO Nobuyuki Hirano spoke with CNBC during an appearance at a conference in Singapore.

18 September 2017
Falcons LB Vic Beasley expected to miss a month with hamstring injury
Beasley was off to another fast start in 2017, recording a sack in each of the Falcons' first two games. He already had picked up a sack in each of the Falcons' first two games this season.

18 September 2017
Neville Rodie & Shaw Inc. Decreases Stake in Walt Disney Company (The) (DIS)
The entertainment giant reported $1.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.05. The analysts estimated EPS for the higher end at 1.63 and lower end at 1.49 while the year ago reported earnings per share was 0.

18 September 2017
Fosun to acquire Gland Pharma, with smaller stake
Raju, will remain on the Gland board and the current management team will continue to run the company. Fosun Pharma shares yesterday jumped as much as 4.3 percent in Shanghai.

18 September 2017
Source Says Nicki Minaj And Nas Have Been Dating Since May
According to Nasty Nas , the '80s-themed shoot was part of an upcoming video, which will be released soon. Recently, a report surfaced about just how much Nicki cares about her bae.

18 September 2017
Investment Research Analysts Opinion: Forterra, Inc. (FRTA), Arrowhead Pharmaceuticals, Inc. (ARWR)
ARWR is now overvalued by 135.33% relative to the average 1-year price target of $1.50 taken from a group of Wall Street Analysts. Analysts have placed a $1.5 price target on Arrowhead Pharmaceuticals, Inc., suggesting a -56.27% decline from recent close.